![Claudia Mitchell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claudia Mitchell
Director/Board Member at
GUBRA A/S
Net worth: 41 935 $ as of 30/06/2026
Profile
Claudia Mitchell was the founder of Halo-Bio RNAi Therapeutics, Inc., founded in 2008, serving as Chief Scientific Officer from 2008 to 2011.
Dr. Mitchell is also the founder of Universal Cells, Inc...
Current jobs include Director at Gubra A starting in 2025, Director at Life Science Washington, Independent Non-Executive Director at Horama SA since 2022, and Board Member at Reaction Capital since 2019.
Former jobs include Independent Director at Adocia SA from 2021 to 2024, Director at French-American Chamber of Commerce, Director at Alliance for Regenerative Medicine, Member of board at Cci France International from 2017 to 2019, and Senior VP-Product & Portfolio Strategy at Astellas Pharma, Inc. Education includes an MBA from Ecole Des Ponts Business School and a doctorate from Universite Paris Cite.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GUBRA A/S 0.01% | 31/12/2025 | 852 ( 0.01% ) | 41 935 $ | 30/06/2026 |
Claudia Mitchell active positions
| Companies | Position | Start |
|---|---|---|
| GUBRA A/S | Director/Board Member | 01/04/2025 |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Director/Board Member | - |
Reaction Capital
 Reaction Capital Investment ManagersFinance Reaction invests in companies located across the globe. The firm targets companies operating in the fields of world health, environmental sustainability and Innovation Equity. It provides financing for early stage capital requirements. | Director/Board Member | 01/07/2019 |
Horama SA
 Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Director/Board Member | 20/10/2022 |
Former positions of Claudia Mitchell
| Companies | Position | End |
|---|---|---|
| ADOCIA | Director/Board Member | 13/06/2024 |
Cci France International
 Cci France International Miscellaneous Commercial ServicesCommercial Services Operates as an independent association that brings together french and foreign companies | Director/Board Member | 01/02/2019 |
Halo-Bio RNAi Therapeutics, Inc.
 Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Develops multi-gene targeting products for the treatment of disease | Founder | 01/02/2011 |
French-American Chamber of Commerce
 French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Director/Board Member | - |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Training of Claudia Mitchell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Developing, licenses and commercializes stem cell therapies | Health Technology |
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
French-American Chamber of Commerce
French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Halo-Bio RNAi Therapeutics, Inc.
Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Develops multi-gene targeting products for the treatment of disease | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Health Technology |
Cci France International
Cci France International Miscellaneous Commercial ServicesCommercial Services Operates as an independent association that brings together french and foreign companies | Commercial Services |
Gubra A/S
 Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
Ecole Des Ponts Business School
 Ecole Des Ponts Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reaction Capital
Reaction Capital Investment ManagersFinance Reaction invests in companies located across the globe. The firm targets companies operating in the fields of world health, environmental sustainability and Innovation Equity. It provides financing for early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Claudia Mitchell
